CoreRx Inc. receives approval for Schedule I controlled drug manufacture

Approval now extends ability to develop and manufacture all scheduled…

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER

CORERX, INC. FULLY OPERATIONAL IN NEW PRODUCT DEVELOPMENT CENTER Company…
graph lab
science white paper
science white paper

CoreRx, Inc. Announces Commercial Supply Agreement for Aimmune Therapeutics’ Investigational Peanut Allergy Treatment

Clearwater, Florida, May 14, 2019 — CoreRx, Inc. today announced that…
science white paper

CoreRx, Inc. announces that its client Bionpharma has received FDA approval for a generic version of ONFI® (Clobazam)

Clearwater, Florida- November 4, 2018 - CoreRx, Inc. announces…
science white paper

Installation of the Optel Line Master Serialization and Aggregation

Clearwater, Florida – As part of CoreRx, Inc’s growth in…